Launched on 6 October 2026Last updated on

Cath: Hemodynamic study; Qp/Qs and PVR

Calculates the shunt ratio from oxygen saturations, mixed venous saturation by the Flamm formula ((3 × SVC + IVC) ÷ 4) or SVC alone, pulmonary and systemic flow by the Fick principle (VO2 measured, by LaFarge and Miettinen from age, sex and heart rate, or 125 mL/min/m²), and pulmonary and systemic vascular resistance (Wood units and indexed). Finds a significant oxygen step-up along the oximetry run (SVC, IVC, high, mid and low RA, RV, PA) and suggests the lesion by its level. Repeats the calculation on 100% oxygen (with dissolved O2 from the pO2) and after a vasodilator (inhaled NO, iloprost, sildenafil, epoprostenol or adenosine) and reads the response: shunt operability by AHA/ATS 2015 (PVRi < 6 WU·m², PVR/SVR < 0.3) and the INOP criterion (PVR/SVR < 0.33 on O2 + NO), or a PAH responder by ESC/ERS 2022 (adults) and the modified Barst criteria (children). Interprets operability of a left-to-right shunt by ESC 2020 PVR thresholds in adults, and in children by the European Paediatric Pulmonary Vascular Disease Network 2019 (PVRi < 6 WU·m² closure, 6–8 grey zone, > 8 contraindicated) beside AHA/ATS 2015, with the vasoreactivity testing agent to use when inhaled NO is not available.

Upload a report, lab sheet or echo picture to fill this calculator automatically.
Patient

Shared by all paediatric tools; BSA fills itself

Oxygen saturations
Baseline run, breathing room air or FiO₂ ≤ 0.3 (dissolved O₂ ignored)
Oxygen consumption

Assumed VO₂ can be wrong by ± 25%, especially in infants and under sedation: it changes the flows and PVR but not Qp/Qs.

Pressures (mean)
mmHg
PVR reactivity: 100% O₂ and vasodilator
Repeat saturations and pressures after each step; VO₂ and Hb as at baseline
Qp/Qs (oximetry)
Enter the aortic, SVC, PA (and pulmonary vein) saturations.
Print / Save PDF: opens the print dialog with a table of the inputs and result; choose Save as PDF to keep a file. Made on this device only; nothing is uploaded.
References
  1. Flamm MD, Cohn KE, Hancock EW. Measurement of systemic cardiac output at rest and exercise in patients with atrial septal defect. Am J Cardiol 1969;23:258-265.
  2. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res 1970;4:23-30.
  3. Antman EM, Marsh JD, Green LH, Grossman W. Blood oxygen measurements in the assessment of intracardiac left to right shunts: a critical appraisal of methodology. Am J Cardiol 1980;46:265-271.
  4. Balzer DT, Kort HW, Day RW, et al. Inhaled nitric oxide as a preoperative test (INOP Test I): the INOP Test Study Group. Circulation 2002;106(12 Suppl 1):I76-I81.
  5. Abman SH, Hansmann G, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation 2015;132:2037-2099.
  6. Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension: the European Paediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant 2019;38:879-901.
  7. Baumgartner H, De Backer J, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021;42:563-645.
  8. Stout KK, Daniels CJ, et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease. Circulation 2019;139:e698-e800.
  9. Galiè N, Humbert M, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2016;37:67-119.
  10. Humbert M, Kovacs G, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022;43:3618-3731.